W. Marc Hertz, Ph.D.
Board Member
GRI Bio, Inc. (GRI)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About W. Marc Hertz, Ph.D.
W. Marc Hertz, Ph.D. is recorded as CEO and Board Member at GRI Bio, Inc. (GRI). GRI Bio, Inc. reported in an 8-K filed April 21, 2023 that W. Marc Hertz, Ph.D. was appointed Director, effective April 21, 2023. GRI Bio, Inc. reported in an 8-K filed April 21, 2023 that W. Marc Hertz, Ph.D. was appointed Chief Executive Officer (principal executive officer), effective April 21, 2023.
“the Board appointed W. Marc Hertz, Ph.D., David Szekeres, Roelof Rongen and Camilla V. Simpson, M.Sc. to the Board.”
“the Board appointed W. Marc Hertz, Ph.D. as the Company's Chief Executive Officer (principal executive officer), Leanne Kelly as the Company's Chief Financial Officer (principal financial and accounting officer), Vipin Kumar Chaturvedi, Ph.D. as the Company's Chief Scientific Officer, and Albert Agro, Ph.D. as the Company's Chief Medical Officer, each effective as of the Closing and to hold office until his or her respective successor(s) shall have been duly elected and qualified or until his or her earlier resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-04-21–present
-
Current
2023-04-21–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at GRI Bio, Inc.
Other people whose current roles at this company are on record from its filings.
- W. Marc Hertz CEO, Board Member
- David Szekeres Chairman, Board Member
- Leanne Kelly CFO
- Leanne M. Kelly CFO
- Camilla V. Simpson Board Member
- Camilla V. Simpson, M.Sc Board Member
- Camilla V. Simpson, M.Sc. Board Member
- David Baker Board Member
- Roelof Rongen Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.